Cargando…
Yiyi Fuzi Baijiang Decoction Alleviates Ulcerative Colitis Partly by Regulating TLR4-Mediated PI3K/Akt and NF-κB Pathways
Yiyi Fuzi Baijiang Decoction (YFBD), an ancient prescription developed by the ancient Chinese physician, Zhang Zhongjing, has shown remarkable effects in treating ulcerative colitis (UC). However, there are few studies on its mechanism. This study was designed to explore the potential mechanism of Y...
Autores principales: | Chen, Liping, Zhang, Chunyu, Cao, Jingjing, Bei, Ge, Wang, Xiaoyu, Miao, Zhiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863463/ https://www.ncbi.nlm.nih.gov/pubmed/35211182 http://dx.doi.org/10.1155/2022/8780514 |
Ejemplares similares
-
Identification of the effect and mechanism of Yiyi Fuzi Baijiang powder against colorectal cancer using network pharmacology and experimental validation
por: Xiang, Bin, et al.
Publicado: (2022) -
Yiyi Fuzi Baijiang Powder Alleviates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats via Inhibiting the TLR4/NF-κB/NLRP3 Inflammasome Signaling Pathway to Repair the Intestinal Epithelial Barrier, and Modulating Intestinal Microbiota
por: Yang, Jinguang, et al.
Publicado: (2023) -
Dahuang Fuzi Baijiang decoction restricts progenitor to terminally exhausted T cell differentiation in colorectal cancer
por: Xu, Yihua, et al.
Publicado: (2022) -
Transcriptomic Analysis of Fuzi Lizhong Decoction for the Treatment of Stomach Ulcers
por: Xin, Yang, et al.
Publicado: (2020) -
Fuzi-Lizhong Decoction Alleviates Nonalcoholic Fatty Liver Disease by Blocking TLR4/MyD88/TRAF6 Signaling
por: Yang, Jiayao, et al.
Publicado: (2022)